HSP90AA1 and melanoma: These results also support our in vivo observation that mouse melanoma tissues exhibit time-of-day–dependent responses to an HSP90 inhibitor in phase with the diurnal cycling of Hsp90aa1 and Hsp90b1 (Fig. 5, F to J, and figs.